Click for best price
Neratinib Market Size, Share 2024
| Market size in 2024 |
US$ 234 million
|
Forecast Market size by 2030 |
US$ 389 million
|
| Growth Rate |
CAGR of 8.8% |
Number of Pages |
95 Pages |
The global Neratinib market size was valued at US$ 234 million in 2024 and is projected to reach US$ 389 million by 2030, at a CAGR of 8.8% during the forecast period 2024-2030.
United States Neratinib market size was valued at US$ 76 million in 2024 and is projected to reach US$ 122 million by 2030, at a CAGR of 8.2% during the forecast period 2024-2030.
A tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer.
Growth driven by increasing incidence of HER2-positive breast cancer. Expanding indications in early-stage and metastatic settings. Development of combination therapies to overcome resistance mechanisms.
Report Overview
This report provides a deep insight into the global Neratinib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neratinib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neratinib market in any manner.
Global Neratinib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Puma Biotechnology
- Beacon Pharmaceuticals Limited
Market Segmentation (by Type)
- 40mg/180 Tablets
- 40mg/150 Tablets
- 40mg/90 Tablets
Market Segmentation (by Application)
- Early Breast Cancer
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neratinib Market
- Overview of the regional outlook of the Neratinib Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
| Report Attributes |
Report Details |
| Report Title |
Global Neratinib Market Research Report 2024(Status and Outlook) |
| Market size in 2024 |
US$ 234 million
|
| Forecast Market size by 2030 |
US$ 389 million
|
| Growth Rate |
CAGR of 8.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
95 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neratinib
1.2 Key Market Segments
1.2.1 Neratinib Segment by Type
1.2.2 Neratinib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neratinib Market Overview
2.1 Global Market Overview
2.1.1 Global Neratinib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neratinib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neratinib Market Competitive Landscape
3.1 Global Neratinib Sales by Manufacturers (2019-2024)
3.2 Global Neratinib Revenue Market Share by Manufacturers (2019-2024)
3.3 Neratinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neratinib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neratinib Sales Sites, Area Served, Product Type
3.6 Neratinib Market Competitive Situation and Trends
3.6.1 Neratinib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neratinib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neratinib Industry Chain Analysis
4.1 Neratinib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neratinib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neratinib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neratinib Sales Market Share by Type (2019-2024)
6.3 Global Neratinib Market Size Market Share by Type (2019-2024)
6.4 Global Neratinib Price by Type (2019-2024)
7 Neratinib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neratinib Market Sales by Application (2019-2024)
7.3 Global Neratinib Market Size (M USD) by Application (2019-2024)
7.4 Global Neratinib Sales Growth Rate by Application (2019-2024)
8 Neratinib Market Segmentation by Region
8.1 Global Neratinib Sales by Region
8.1.1 Global Neratinib Sales by Region
8.1.2 Global Neratinib Sales Market Share by Region
8.2 North America
8.2.1 North America Neratinib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neratinib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neratinib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neratinib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neratinib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Puma Biotechnology
9.1.1 Puma Biotechnology Neratinib Basic Information
9.1.2 Puma Biotechnology Neratinib Product Overview
9.1.3 Puma Biotechnology Neratinib Product Market Performance
9.1.4 Puma Biotechnology Business Overview
9.1.5 Puma Biotechnology Neratinib SWOT Analysis
9.1.6 Puma Biotechnology Recent Developments
9.2 Beacon Pharmaceuticals Limited
9.2.1 Beacon Pharmaceuticals Limited Neratinib Basic Information
9.2.2 Beacon Pharmaceuticals Limited Neratinib Product Overview
9.2.3 Beacon Pharmaceuticals Limited Neratinib Product Market Performance
9.2.4 Beacon Pharmaceuticals Limited Business Overview
9.2.5 Beacon Pharmaceuticals Limited Neratinib SWOT Analysis
9.2.6 Beacon Pharmaceuticals Limited Recent Developments
10 Neratinib Market Forecast by Region
10.1 Global Neratinib Market Size Forecast
10.2 Global Neratinib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neratinib Market Size Forecast by Country
10.2.3 Asia Pacific Neratinib Market Size Forecast by Region
10.2.4 South America Neratinib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neratinib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neratinib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neratinib by Type (2025-2030)
11.1.2 Global Neratinib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neratinib by Type (2025-2030)
11.2 Global Neratinib Market Forecast by Application (2025-2030)
11.2.1 Global Neratinib Sales (Kilotons) Forecast by Application
11.2.2 Global Neratinib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neratinib Market Size Comparison by Region (M USD)
Table 5. Global Neratinib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neratinib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neratinib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neratinib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neratinib as of 2022)
Table 10. Global Market Neratinib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neratinib Sales Sites and Area Served
Table 12. Manufacturers Neratinib Product Type
Table 13. Global Neratinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neratinib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neratinib Market Challenges
Table 22. Global Neratinib Sales by Type (Kilotons)
Table 23. Global Neratinib Market Size by Type (M USD)
Table 24. Global Neratinib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neratinib Sales Market Share by Type (2019-2024)
Table 26. Global Neratinib Market Size (M USD) by Type (2019-2024)
Table 27. Global Neratinib Market Size Share by Type (2019-2024)
Table 28. Global Neratinib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neratinib Sales (Kilotons) by Application
Table 30. Global Neratinib Market Size by Application
Table 31. Global Neratinib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neratinib Sales Market Share by Application (2019-2024)
Table 33. Global Neratinib Sales by Application (2019-2024) & (M USD)
Table 34. Global Neratinib Market Share by Application (2019-2024)
Table 35. Global Neratinib Sales Growth Rate by Application (2019-2024)
Table 36. Global Neratinib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neratinib Sales Market Share by Region (2019-2024)
Table 38. North America Neratinib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neratinib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neratinib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neratinib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neratinib Sales by Region (2019-2024) & (Kilotons)
Table 43. Puma Biotechnology Neratinib Basic Information
Table 44. Puma Biotechnology Neratinib Product Overview
Table 45. Puma Biotechnology Neratinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Puma Biotechnology Business Overview
Table 47. Puma Biotechnology Neratinib SWOT Analysis
Table 48. Puma Biotechnology Recent Developments
Table 49. Beacon Pharmaceuticals Limited Neratinib Basic Information
Table 50. Beacon Pharmaceuticals Limited Neratinib Product Overview
Table 51. Beacon Pharmaceuticals Limited Neratinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Beacon Pharmaceuticals Limited Business Overview
Table 53. Beacon Pharmaceuticals Limited Neratinib SWOT Analysis
Table 54. Beacon Pharmaceuticals Limited Recent Developments
Table 55. Global Neratinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Neratinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Neratinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Neratinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Neratinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Neratinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Neratinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Neratinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Neratinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Neratinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Neratinib Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Neratinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Neratinib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Neratinib Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Neratinib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Neratinib Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Neratinib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Neratinib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neratinib Market Size (M USD), 2019-2030
Figure 5. Global Neratinib Market Size (M USD) (2019-2030)
Figure 6. Global Neratinib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neratinib Market Size by Country (M USD)
Figure 11. Neratinib Sales Share by Manufacturers in 2023
Figure 12. Global Neratinib Revenue Share by Manufacturers in 2023
Figure 13. Neratinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neratinib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neratinib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neratinib Market Share by Type
Figure 18. Sales Market Share of Neratinib by Type (2019-2024)
Figure 19. Sales Market Share of Neratinib by Type in 2023
Figure 20. Market Size Share of Neratinib by Type (2019-2024)
Figure 21. Market Size Market Share of Neratinib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neratinib Market Share by Application
Figure 24. Global Neratinib Sales Market Share by Application (2019-2024)
Figure 25. Global Neratinib Sales Market Share by Application in 2023
Figure 26. Global Neratinib Market Share by Application (2019-2024)
Figure 27. Global Neratinib Market Share by Application in 2023
Figure 28. Global Neratinib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neratinib Sales Market Share by Region (2019-2024)
Figure 30. North America Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neratinib Sales Market Share by Country in 2023
Figure 32. U.S. Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neratinib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neratinib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neratinib Sales Market Share by Country in 2023
Figure 37. Germany Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neratinib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neratinib Sales Market Share by Region in 2023
Figure 44. China Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neratinib Sales and Growth Rate (Kilotons)
Figure 50. South America Neratinib Sales Market Share by Country in 2023
Figure 51. Brazil Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neratinib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neratinib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neratinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neratinib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neratinib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neratinib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neratinib Market Share Forecast by Type (2025-2030)
Figure 65. Global Neratinib Sales Forecast by Application (2025-2030)
Figure 66. Global Neratinib Market Share Forecast by Application (2025-2030)
